Further investigations are required to determine the effects of anti-AR therapy on chemosensitivity, especially in animal models for bladder cancer, and to elucidate the precise mechanisms of how AR signals involve CDDP resistance in bladder cancer cells. The gene discussed is AR; the disease is urinary bladder carcinoma.